$ASND

2 theses

bullish 50%neutral 0%bearish 50%

Avg return (6m)

—

Win rate (6m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 2, 4:30 PM ET

$ASNDSEC Form 4bearish

Bodenhoff Mads · SVP & PAO at Ascendis Pharma A/S · 24d agono track record yet

Sold 3,000 @ $270.19 avg · $810,570 · 2026-09-08

Form 4: Bodenhoff Mads sold ASND

Bodenhoff Mads (SVP & PAO at Ascendis Pharma A/S) reported an open-market sale of 3,000 shares of ASND at an average $270.19, roughly $810,570, in a Form 4 filed 2026-09-09.

At post $260.81Now $227.87-12.6% since postedas of Oct 2, 4:30 PM ET

1d+0.2%

3d+1.0%

1w-5.0%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$ASNDSEC Form 4bullish

BIENAIME JEAN JACQUES · Ascendis Pharma A/S · 45d agono track record yet

Long 2,000 shares of ASND

Bought 2,000 @ $246.33 avg · $492,654 · 2026-08-14

Form 4: BIENAIME JEAN JACQUES bought ASND

BIENAIME JEAN JACQUES (Director at Ascendis Pharma A/S) reported an open-market purchase of 2,000 shares of ASND at an average $246.33, roughly $492,654, in a Form 4 filed 2026-08-18.

At post $248.85Now $227.87-8.4% since postedas of Oct 2, 4:30 PM ET

1d+4.3%

3d+1.8%

1w+1.7%

1m-3.9%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.